FolioLanternBeta
CORTCorcept Therapeutics Inc

Joseph Belanoff

Chief Executive Officer, Director at Corcept Therapeutics Inc, as of Jun 2, 2026Sold $10.4M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
5.7%
share of stake sold at Corcept Therapeutics Inc
2.87M
shares held after the latest filing, Corcept Therapeutics Inc
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $3.0M under a disclosed planNovDec 2025: $3.2M under a disclosed plan$3.2MDecJanFebMar 2026: $1.3M under a disclosed planMarAprMay 2026: $2.0M under a disclosed planMayJun 2026: $895K under a disclosed planJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Corcept Therapeutics Inc (CORT)Chief Executive Officer, DirectorApr 14, 2004Jun 2, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.